Table 3 Correlation of NBS1 protein level and clinicopathological parameters
From: Clinicopathological values of NBS1 and DNA damage response genes in epithelial ovarian cancers
NBS1 expression | ||||
|---|---|---|---|---|
Number of patients | Negative | Positive | P-value | |
FIGO stage | ||||
 Early (I, II) | 36 | 16 | 20 | 0.001 |
 Advanced (III, IV) | 104 | 13 | 91 | |
Histology | ||||
 Serous | 82 | 11 | 71 | 0.008 |
 Non-serous | 58 | 22 | 36 | |
Grade | ||||
 1 | 23 | 14 | 9 | 0.001 |
 2 and 3 | 117 | 16 | 101 | |
Residual tumor | ||||
 ⩽1 cm | 73 | 28 | 45 | 0.021 |
 >1 cm | 67 | 5 | 62 | |
